Home LiteratureArticle Details
PMID: 17045473 Published · ppublish English

Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.

van Oostrom Iris, Meijers-Heijboer Hanne, Duivenvoorden Hugo J, Bröcker-Vriends Annette H J T, van Asperen Christi J, Sijmons Rolf H, Seynaeve Caroline, Van Gool Arthur R, Klijn Jan G M, Tibben Aad

Abstract

This study explored predictors for hereditary cancer distress six months after genetic susceptibility testing for a known familial BRCA1/2 or HNPCC related mutation, in order to gain insight into aspects relevant for the identification of individuals needing additional psychosocial support. Coping, illness representations, experiences with cancer in relatives and family system characteristics were assessed in 271 applicants for genetic testing before result disclosure. Hereditary cancer distress was assessed prospectively up to six months after disclosure. Regression analysis revealed that the pretest level of distress, complicated grief, the number of affected first-degree relatives and strong emotional illness representations were factors that best explained hereditary cancer distress. Other significant predictors were illness coherence, passive coping, distraction seeking, being aged <13 years when a parent was affected by cancer and family communication. Individuals who may benefit from additional support may be identified before result disclosure using a short instrument assessing the relevant aspects.

Article Info
Journal
European journal of cancer (Oxford, England : 1990)
Abbr.
Eur J Cancer
Published
2007-03-26
Indexed
2007-01-15
Updated
2009-11-19
Language
English
Country/Region
England
NLM ID
9005373
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com